Effect of of Inhalation of Thyme Oil in COVID-19

Phase 2

Recruiting

Conditions: COVID-19.
COVID-19, virus identified
U07.1

Registration Number: IRCT20200426047212N1

Lead Sponsor: Shooshtar University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 48

Inclusion Criteria

Age over 18 years
Mild to moderate disease
Positive polymerase chain reaction (PCR) test
Lung involvement based on CT scan
Hospitalization

Exclusion Criteria

Patient death
Sensitivity to inhalation of the drug
Intolerance of nebulizer
Physician's diagnosis of not participating in the study
Pregnancy and lactation
Use of angiotensin-converting enzyme inhibitor
Severe renal, hepatic, respiratory and cardiovascular failure
Taking cytotoxic or corticosteroid drugs
Transfer to another hospital

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of oxygen saturation. Timepoint: Before the start of the intervention, 5 consecutive days during the intervention and one day after the intervention. Method of measurement: Pulse oximeter.;Respiratory rate. Timepoint: Before the start of the intervention, 5 consecutive days during the intervention and one day after the intervention. Method of measurement: Count the respiratory rate per minute.

Secondary Outcome Measures

Name	Time	Method
C-Reactive Protein. Timepoint: Before the intervention and one day in between during the intervention until discharge. Method of measurement: Venous blood test.;White blood cell. Timepoint: Before the intervention and one day in between during the intervention until discharge. Method of measurement: Venous blood test.;Neutrophil. Timepoint: Before the intervention and one day in between during the intervention until discharge. Method of measurement: Venous blood test.;Lymphocytes. Timepoint: Before the intervention and one day in between during the intervention until discharge. Method of measurement: Venous blood test.;Red blood count. Timepoint: Before the intervention and one day in between during the intervention until discharge. Method of measurement: Venous blood test.;Erythrocyte sedimentation rate. Timepoint: Before the intervention and one day in between during the intervention until discharge. Method of measurement: Venous blood test.